Article Versions Notes

Hallqvist A, Svensson J, Hagmarker L, Marin I, Rydén T, Beauregard J-M, Bernhardt P. Optimizing the Schedule of PARP Inhibitors in Combination with ¹⁷⁷Lu-DOTATATE: A Dosimetry Rationale. Biomedicines. 2021; 9(11):1570. https://doi.org/10.3390/biomedicines9111570

Hallqvist, Andreas, Johanna Svensson, Linn Hagmarker, Ida Marin, Tobias Rydén, Jean-Mathieu Beauregard, and Peter Bernhardt. 2021. "Optimizing the Schedule of PARP Inhibitors in Combination with ¹⁷⁷Lu-DOTATATE: A Dosimetry Rationale" Biomedicines 9, no. 11: 1570. https://doi.org/10.3390/biomedicines9111570

Hallqvist, A., Svensson, J., Hagmarker, L., Marin, I., Rydén, T., Beauregard, J.-M., & Bernhardt, P. (2021). Optimizing the Schedule of PARP Inhibitors in Combination with ¹⁷⁷Lu-DOTATATE: A Dosimetry Rationale. Biomedicines, 9(11), 1570. https://doi.org/10.3390/biomedicines9111570